Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-05-31 17:45 |
Valneva Appoints Dr. Thomas Decker and Dr. Michael Pfleiderer to its Scientific…
|
English | 157.1 KB | ||
| 2022-05-25 07:00 |
Valneva achève avec succès l’essai d’homogénéité des lots cliniques de son cand…
|
French | 205.3 KB | ||
| 2022-05-25 07:00 |
Valneva Successfully Completes Lot-to-Lot Consistency Trial for its Single-Shot…
|
English | 162.0 KB | ||
| 2022-05-19 07:00 |
L'EMA accepte la soumission du dossier d’autorisation de mise sur le marché du …
|
French | 146.2 KB | ||
| 2022-05-19 07:00 |
EMA Accepts Filing of Marketing Authorization Application for Valneva’s Inactiv…
|
English | 146.3 KB | ||
| 2022-05-16 07:15 |
Valneva Receives Notice of European Commission’s Intent to Terminate COVID-19 V…
|
English | 184.8 KB | ||
| 2022-05-16 07:15 |
Valneva reçoit de la Commission Européenne un avis d’intention de résiliation d…
|
French | 183.7 KB | ||
| 2022-05-16 07:00 |
Les Émirats arabes unis autorisent l’utilisation d’urgence du vaccin inactivé d…
|
French | 178.9 KB | ||
| 2022-05-16 07:00 |
Valneva Receives Emergency Use Authorization from the United Arab Emirates for …
|
English | 142.0 KB | ||
| 2022-05-05 07:00 |
Valneva Reports Q1 2022 Results and Provides Corporate Updates
|
English | 307.2 KB | ||
| 2022-05-05 07:00 |
Valneva publie ses résultats financiers du premier trimestre 2022 et fait un po…
|
French | 292.8 KB | ||
| 2022-05-04 17:45 |
Valneva lance un essai clinique évaluant son candidat vaccin contre la COVID-19…
|
French | 118.6 KB | ||
| 2022-05-04 17:45 |
Valneva Initiates Heterologous Booster Trial of Inactivated, COVID-19 Vaccine C…
|
English | 148.0 KB | ||
| 2022-05-03 18:00 |
VALNEVA Déclaration d’actions et de droits de vote - 30 avril 2022
|
French | 17.7 KB | ||
| 2022-05-03 18:00 |
VALNEVA Declaration of shares and voting rights - April 30, 2022
|
English | 17.6 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
